Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 10
Submit an article Journal homepage
3,082
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Ruxolitinib is effective in patients with intermediate-1 risk myelofibrosis: a summary of recent evidence

Claire N. HarrisonDepartment of Haematology, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK; Correspondence[email protected]
,
Moshe TalpazComprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA;
&
Adam J. MeadMRC Weatherall Institute of Molecular Medicine and NIHR Biomedical Research Centre, University of Oxford, Oxford, UK
Pages 2259-2267 | Received 09 May 2016, Accepted 22 May 2016, Published online: 27 Jul 2016
Supplemental material

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Download Zip (3.7 MB)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.